Logo image of DRIO

DARIOHEALTH CORP (DRIO) Stock Fundamental Analysis

NASDAQ:DRIO - Nasdaq - US23725P2092 - Common Stock - Currency: USD

0.709  +0.01 (+1.29%)

After market: 0.7097 +0 (+0.1%)

Fundamental Rating

2

DRIO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 36 industry peers in the Health Care Technology industry. DRIO has a bad profitability rating. Also its financial health evaluation is rather negative. DRIO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DRIO had negative earnings in the past year.
In the past year DRIO has reported a negative cash flow from operations.
In the past 5 years DRIO always reported negative net income.
In the past 5 years DRIO always reported negative operating cash flow.
DRIO Yearly Net Income VS EBIT VS OCF VS FCFDRIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

DRIO's Return On Assets of -33.36% is on the low side compared to the rest of the industry. DRIO is outperformed by 69.44% of its industry peers.
DRIO has a Return On Equity (-52.33%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -33.36%
ROE -52.33%
ROIC N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
DRIO Yearly ROA, ROE, ROICDRIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 -600 -800

1.3 Margins

With a Gross Margin value of 52.50%, DRIO perfoms like the industry average, outperforming 47.22% of the companies in the same industry.
DRIO's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for DRIO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
DRIO Yearly Profit, Operating, Gross MarginsDRIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

3

2. Health

2.1 Basic Checks

DRIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
DRIO has more shares outstanding than it did 1 year ago.
DRIO has more shares outstanding than it did 5 years ago.
DRIO has a better debt/assets ratio than last year.
DRIO Yearly Shares OutstandingDRIO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DRIO Yearly Total Debt VS Total AssetsDRIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

DRIO has an Altman-Z score of -5.41. This is a bad value and indicates that DRIO is not financially healthy and even has some risk of bankruptcy.
DRIO's Altman-Z score of -5.41 is on the low side compared to the rest of the industry. DRIO is outperformed by 77.78% of its industry peers.
DRIO has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
DRIO has a Debt to Equity ratio (0.26) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -5.41
ROIC/WACCN/A
WACC13.05%
DRIO Yearly LT Debt VS Equity VS FCFDRIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

DRIO has a Current Ratio of 2.01. This indicates that DRIO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.01, DRIO is in line with its industry, outperforming 58.33% of the companies in the same industry.
DRIO has a Quick Ratio of 1.77. This is a normal value and indicates that DRIO is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.77, DRIO perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 1.77
DRIO Yearly Current Assets VS Current LiabilitesDRIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 68.36% over the past year.
DRIO shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.21%.
DRIO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.03% yearly.
EPS 1Y (TTM)68.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)47.21%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%17.26%

3.2 Future

Based on estimates for the next years, DRIO will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.05% on average per year.
The Revenue is expected to grow by 19.26% on average over the next years. This is quite good.
EPS Next Y-40.66%
EPS Next 2Y-17.91%
EPS Next 3Y-23.68%
EPS Next 5Y17.05%
Revenue Next Year19.45%
Revenue Next 2Y18.27%
Revenue Next 3Y19.88%
Revenue Next 5Y19.26%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DRIO Yearly Revenue VS EstimatesDRIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
DRIO Yearly EPS VS EstimatesDRIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -10 -20 -30 -40

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DRIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DRIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRIO Price Earnings VS Forward Price EarningsDRIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRIO Per share dataDRIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

DRIO's earnings are expected to decrease with -23.68% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.91%
EPS Next 3Y-23.68%

More info and screens

0

5. Dividend

5.1 Amount

DRIO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DARIOHEALTH CORP

NASDAQ:DRIO (7/15/2025, 8:00:01 PM)

After market: 0.7097 +0 (+0.1%)

0.709

+0.01 (+1.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners22.14%
Inst Owner Change0%
Ins Owners7.68%
Ins Owner Change6.65%
Market Cap31.52M
Analysts82
Price Target2.68 (278%)
Short Float %8.7%
Short Ratio19.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)27.94%
Min EPS beat(2)-17.64%
Max EPS beat(2)73.53%
EPS beat(4)3
Avg EPS beat(4)38.02%
Min EPS beat(4)-17.64%
Max EPS beat(4)85.87%
EPS beat(8)5
Avg EPS beat(8)25.21%
EPS beat(12)8
Avg EPS beat(12)21.03%
EPS beat(16)9
Avg EPS beat(16)14.89%
Revenue beat(2)1
Avg Revenue beat(2)-5.27%
Min Revenue beat(2)-11.45%
Max Revenue beat(2)0.92%
Revenue beat(4)1
Avg Revenue beat(4)-8.67%
Min Revenue beat(4)-22.51%
Max Revenue beat(4)0.92%
Revenue beat(8)1
Avg Revenue beat(8)-11.74%
Revenue beat(12)4
Avg Revenue beat(12)-8.9%
Revenue beat(16)6
Avg Revenue beat(16)-6.07%
PT rev (1m)0%
PT rev (3m)-1.56%
EPS NQ rev (1m)-11.11%
EPS NQ rev (3m)-169.22%
EPS NY rev (1m)-139.72%
EPS NY rev (3m)-151.47%
Revenue NQ rev (1m)0.67%
Revenue NQ rev (3m)-11.03%
Revenue NY rev (1m)6.33%
Revenue NY rev (3m)-1.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.12
P/FCF N/A
P/OCF N/A
P/B 0.43
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.86
Fwd EYN/A
FCF(TTM)-0.73
FCFYN/A
OCF(TTM)-0.72
OCFYN/A
SpS0.63
BVpS1.66
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.36%
ROE -52.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.5%
FCFM N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
F-Score5
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.54%
Cap/Sales 0.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.01
Quick Ratio 1.77
Altman-Z -5.41
F-Score5
WACC13.05%
ROIC/WACCN/A
Cap/Depr(3y)8.55%
Cap/Depr(5y)19.33%
Cap/Sales(3y)1.81%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y-40.66%
EPS Next 2Y-17.91%
EPS Next 3Y-23.68%
EPS Next 5Y17.05%
Revenue 1Y (TTM)47.21%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%17.26%
Revenue Next Year19.45%
Revenue Next 2Y18.27%
Revenue Next 3Y19.88%
Revenue Next 5Y19.26%
EBIT growth 1Y19.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.4%
EBIT Next 3Y25.71%
EBIT Next 5Y16.11%
FCF growth 1Y7.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.94%
OCF growth 3YN/A
OCF growth 5YN/A